Table 1 The characteristics of included RCTs
Study ID | Country | Sample size | Age (years) | BMI (kg/m2) | FIGO (IA2/IB1/IB2/IIA/IIB, n) | Neoadjuvant chemotherapy | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
LNSRH | LRH | LNSRH | LRH | LNSRH | LRH | LNSRH | LRH | LNSRH | LRH | ||
Fu 2016 | China | 21 | 23 | 42.6 ± 8.9 | 43.1 ± 9.2 | 23.6± 3.8 | 23.6 ± 4.2 | NA | NA | 0 | 0 |
Li 2009 | China | 25 | 25 | 44.02 ± 9.15 | 43.87 ± 8.91 | 22.64 ± 3.78 | 23.11 ± 4.81 | NA | NA | NA | NA |
Li 2020 | China | 34 | 34 | 43. 19 ± 6. 98 | 43. 06 ± 6. 82 | 23. 57 ± 1. 78 | 23. 61 ± 1. 85 | 0/15/8/11/0 | 0/16/9/9/0 | 0 | 0 |
Liu 2010 | China | 41 | 46 | 42.5 ± 9.4 | 44.0 ± 8.0 | 23.3 ± 4.1 | 22.1 ± 5.2 | 0/7/16/18/0 | 0/9/15/22/0 | NA | NA |
Luo 2012 | China | 26 | 32 | 43.0 ± 10.0 | 44.0 ± 9.0 | NA | NA | 0/7/10/9/0 | 0/10/15/7/0 | 0 | 0 |
Wei 2014 | China | 32 | 20 | 41.93 ± 8.66 | 42.09±9.15 | NA | NA | NA | NA | 0 | 0 |
Xia 2016 | China | 116 | 119 | 42.32 ± 9.79 | 42.76±10.11 | 22.74 ± 3.12 | 22.18±4.01 | NA | NA | NA | NA |
Xie 2015 | China | 45 | 45 | 43.5 ± 3.8 | 43.4 ± 4.0 | 23.5 ± 2.1 | 23.6 ± 1.9 | 0/31/7/7/0 | 0/32/5/8/0 | 0 | 0 |
Zhang 2010 | China | 17 | 18 | 41.0 ± 8.0 | 39.0 ± 6.0 | 24.2 ± 3.5 | 24.4 ± 3.1 | 3/6/5/3/0 | 2/8/4/4/0 | NA | NA |
Zhang 2014 | China | 15 | 33 | 43.4 ± 11.2 | 48.3 ± 8.7 | NA | NA | NA | NA | NA | 8 |
Zhao 2011 | China | 17 | 13 | 39.7 ± 8.4 | 43.2 ± 9.4 | NA | NA | 7/9/0/1/0 | 4/4/0/5/0 | 0 | 0 |
Zhu 2011 | China | 38 | 43 | 43.0 ± 11.0 | 44.0 ± 10.0 | NA | NA | 15/20/0/3/0 | 17/22/0/4/0 | 0 | 0 |
Zhu 2017 | China | 62 | 62 | 42.0 ± 6.6 | 41.4 ± 6.4 | NA | NA | 0/33/11/18/0 | 0/38/7/17/0 | NA | NA |